Delivery Order SPE2DB24D2216-SPE2DB25FGMFD

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product used for diabetes management. The total ceiling value of the contract is $6,640.97, with a completion date of December 14, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUMET 50-500 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract has a ceiling value of $8,057.82 and a completion date of June 4, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,211.40, is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and a completion date of February 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,924.75, is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract is a firm fixed-price delivery order with a completion date of May 31, 2024. No set-aside designation was used for this award. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,044.44, is for the supply of JANUMET 50-1,000 MG TABLET 180S, a diabetes medication. The contract has a firm fixed-price pricing structure and a completion date of May 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUMET 50-1,000 MG TABLET 180S, a prescription medication, with a ceiling value of $14,992.86 and a completion date of November 3, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,316.00, is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of August 3, 2022. This award is associated with a larger Indefinite Delivery Contract...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a diabetes medication, with a ceiling value of $3,404.44 and a period of performance through June 11, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and this...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,112.14, is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of March 14, 2025. This contract is not designated as a set-aside, indicating open...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product used in the treatment of diabetes. The contract has a ceiling value of $6,719.63 and a period of performance through January 22, 2024. The contract is a Firm Fixed Price arrangement and was not set aside for any specific...
  • SPE2DB24D2216
    Indefinite Delivery Contract
  • SPE2DB24D2216-SPE2DB25FGMFD
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a diabetes medication, with a firm fixed price and a ceiling value of $2,172.96. The contract has an ultimate completion date of November 25, 2024 and was awarded on November 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle for the DLA Troop Support Medical program through December 2026. The contract is not designated as a set-aside and is open to full and open competition.

Generated 9/3/25, 9:56 AM